Failure to Investigate Insulin Administration Error and Potential Neglect
Summary
The deficiency involves the facility’s failure to initiate an investigation into a potential neglect situation after a medication error involving rapid-acting insulin administration to one resident. The resident had multiple pertinent diagnoses including cancer, cardiorespiratory conditions, diabetes, anxiety, depression, asthma, and respiratory failure, and had a BIMS score of 99 indicating non-participation in the assessment. Hospital discharge orders dated 2/24/26 directed that the resident receive insulin Aspart 1–15 units subcutaneously three times daily with meals, with specific sliding-scale doses based on blood glucose levels. On 3/13/26 at 12:00 p.m., the eMAR showed a blood glucose of 355 mg/dl with documentation indicating the medication was administered, a code for refusal, and an entry of 15 units of Aspart insulin given, and at 5:00 p.m. the eMAR showed a blood glucose of 356 mg/dl with 15 units of Aspart insulin administered. According to nursing documentation, around 8:00 p.m. on 3/13/26 the resident was found with cold, clammy hands, weakness, and a blood glucose of 52 mg/dl, with mental status described as conscious but incoherent and confused. Vital signs at that time included blood pressure 139/78, pulse 61, and oxygen saturation 22. The resident was given juice, and blood glucose rose sequentially to 74 mg/dl and then 92 mg/dl, but the resident remained weak and was hospitalized. An IDT note dated 3/16/26 recorded that the team met to review the rehospitalization for low blood glucose, noting a blood glucose of 33 mg/dl despite facility interventions and that the resident was transferred to the hospital for further evaluation and was currently unresponsive there. In an interview, the resident stated she did not recall the events leading up to the hospitalization. In interviews, RN-A reported that on 3/13/26 at about 2:15 p.m. she heard the resident hysterically crying, checked a blood glucose over 200 mg/dl, and immediately administered 15 units of Aspart insulin. RN-A stated she saw that RN-B had not recorded the noon insulin, told RN-B to chart the insulin as given at noon but not to administer it, and that RN-B did so. RN-A also documented the insulin on the eMAR as given at 5:00 p.m., although she administered it around 2:30 p.m. RN-A stated she called the DON around 3:00 p.m. and explained the medication error and was told the DON would correct the eMAR and write a progress note, but she was unsure if this occurred, and she reported that the facility had not addressed the medication error or charting with her. LPN-A, who was on site that day, reported being aware only of the hospitalization for low glucose and denied knowledge of the incorrect timing of the rapid-acting insulin or any medication error report or re-education. The DON acknowledged being informed by RN-A that the resident’s blood glucose was over 400 mg/dl and that Aspart had been given at 2:15 p.m., stated she instructed RN-A to document the insulin, and, upon reviewing the eMAR during the survey, noted it appeared both RN-A and RN-B had charted the insulin and she was uncertain of the dose given. The DON denied completing a medication error form, conducting an investigation, or re-educating RN-A, and the Administrator stated she was not aware of the medication error, that the incident was not reported, and was unsure if any investigation or re-education occurred. No investigation policy was provided when requested.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release June 24, 2026) and official state health department websites — never guesswork.
Trusted by long-term care providers and associations.



